Korro Bio
Develops RNA editing medicines for rare and prevalent diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Open roles
5
+2 in the last 30 days
Posting views
10
in the last 30 days, +6 vs the 30 before. One visitor counts once per posting per day.
Reply rate
Not enough data yet.
Time a posting stays open
66 days
median over 5 postings closed in the last 6 months
Postings added vs. removed
Who they hire
What the company's open postings ask for.